Drug profile · INN
hydroxyurea
HYDROXYUREA
hydroxyurea (HYDROXYUREA) is a ribonucleoside-diphosphate reductase rr1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — hydroxyurea
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 5
- Data quality
- 0.84
Quick answer
hydroxyurea (HYDROXYUREA) is a ribonucleoside-diphosphate reductase rr1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Ribonucleoside-diphosphate reductase RR1 inhibitor
Primary target: Ribonucleoside-diphosphate reductase RR1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is hydroxyurea?
hydroxyurea (HYDROXYUREA) is a ribonucleoside-diphosphate reductase rr1 inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for hydroxyurea?
HYDROXYUREA is a marketed brand name for hydroxyurea. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydroxyurea?
hydroxyurea has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.